+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Virology"

In Vitro Diagnostics Business Outlook, 2024 (6 updates) - Product Thumbnail Image

In Vitro Diagnostics Business Outlook, 2024 (6 updates)

  • Report
  • January 2024
  • 33 Pages
  • Global
From
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
From
Global Bioanalytical Testing Services Market - Product Thumbnail Image

Global Bioanalytical Testing Services Market

  • Report
  • September 2023
  • 167 Pages
  • Global
From
From
From
Antiviral Combination Therapy Global Market Report 2024 - Product Thumbnail Image

Antiviral Combination Therapy Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Virology Testing Global Market Report 2024 - Product Thumbnail Image

Virology Testing Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator

Virology is a branch of biotechnology that focuses on the study of viruses and their effects on living organisms. It involves the study of the structure, function, and genetics of viruses, as well as their interactions with hosts. Virology also involves the development of vaccines and antiviral drugs to prevent and treat viral infections. Virology has become increasingly important in recent years due to the emergence of new and emerging viral diseases, such as Zika, Ebola, and SARS-CoV-2. Virologists are also involved in the development of gene therapy and gene editing technologies, which have the potential to revolutionize the treatment of many diseases. The virology market is highly competitive, with many companies offering products and services related to the study and treatment of viruses. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, and Gilead Sciences. Show Less Read more